

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S405–S464
S461
2
Hospital Universitario de Álava-Sede Santiago, Psychiatry,
Vitoria-Gasteiz, Spain
3
Hospital Universitario Marqués de Valdecilla, General Medicine,
Santander, Spain
∗
Corresponding author.
Introduction
Paraphrenia is a poorly defined process whose
uncertain origins date back to the German psychiatry mid-
nineteenth century. Paraphrenia would be a subtype of schizophre-
nia characterized by a more benign clinical course in terms of
volitional and emotional involvement. Certain types of serious
sensoperceptive distortions and paranoid symptoms are charac-
teristics of this clinical variant. Despite its diverse presentation,
its chronic development and its presence in the daily lives of the
patient, the overall functionality is not deeply affected.
Objectives
To discuss the validity of this and other clinical
processes based on classical clinical descriptions for diagnostic
approach of our current patients, in contrast to the common use
simplified concept (forgetting in ICD-10 or disappeared in Ameri-
can manuals).
Materials and methods
Clinical case a middle-aged woman diag-
nosed with longstanding paranoid schizophrenia who suffered
from a highly systemized delusional and hallucinatory syndrome
with chronic evolution after a first relapse due to abandonment of
treatment, but keeping high functional performance even during
phases of partial remission.
Conclusions
Schizophrenia presents multiple symptomatic and
prognostic paths. Classical authors named these different subtypes.
Revisiting these subtypes could be useful as a complementary tool
for predicting clinical outcome based on their descriptions, espe-
cially in the absence of reliable material instruments.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.507EV0179
A new syndrome? The sport
identification addiction and the case
of Italian football ultra-fanatical
support
M. Lanzaro
ASL BN 1, Department of Psychiatry, Ottaviano, Italy
The new DSM-5 has a number of changes to addictions and
substance-related disorders. Internet Gaming for instance is a “Con-
dition for Further Study”. This means that it is not an “official”
disorder in the DSM, but one on which the American Psychiatric
Association request additional research.
The DSM diagnostic criteria for addictions to the X-subject gener-
ally include:
– repetitive use of X, that leads to significant issues with function-
ing;
– preoccupation or obsession with X;
– craving/withdrawal symptoms when not dealing with X;
– the person has tried to stop or curb X, but has failed to do so;
– the person has had a loss of interest in other life activities, such
as hobbies;
– a person has had continued overuse of X evenwith the knowledge
of how much they impact a person’s life;
– the person uses X to relieve anxiety related to other issues;
– the person has lost or put at risk and opportunity or relationship
because of X.
I suggest that some sport fans may:
– meet the above mentioned criteria;
– be subject to over-identification with “their team performances”,
superstitious conditioning and loss of self-consciousness that may
lead to a full blown addictive syndrome, along with comorbidity
with pathological gambling.
This seems particularly true in Italy, for example, as far as the phe-
nomenon of ultra football supporters is concerned.
I argue that further research might be needed to explore the
psycho-social consequences of obsessive sport addiction and how
this may impact on a person’s overall functioning.
Disclosure of interest
The author has not supplied his declaration
of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.508EV0180
Depression across DSM and ICD
editions: Psychiatric nosology’s ‘Black
Dog’
R. Leite
∗
, P. Macedo , J. Borges , T. Santos
Baixo Vouga Hospital Centre, Department of Psychiatry and Mental
Health, Aveiro, Portugal
∗
Corresponding author.
Introduction
The diagnosis of depressive disorders has suffered
important modifications throughout DSM and ICD editions. The
history of those modifications is an important subject to fully
understand the current diagnostic criteria and classification, with
milestones often set not by scientific or theoretical data but rather
by political decision and conflicting interests.
Objective
The authors propose a review of how the concept of
major depression has evolved along the several DSM and ICD edi-
tions.
Methods
The results were obtained searching literature included
on the platforms PubMed, Google Scholar, PsycINFO and Psychol-
ogy and Behavioral Sciences Collection.
Results
The current diagnostic entity lacks validity and utility and
that is an obstacle to both scientific research and clinical practice.
Conclusion
The authors also discuss alternative models which
may contribute to a paradigm shift more suitable to clinical reality
and to provide a useful framework for all levels of research.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.509EV0181
A descriptive study of a sample of 42
male diagnosed psychotic disorder
V. Martí Garnica
1 ,∗
, M.D. Ortega Garcia
2, M.A. López Bernal
2,
J.R. Russo De Leom
3, S. Marin Garcia
41
Servicio Murciano de Salud, CSM San Andres, Murcia, Spain
2
Servicio Murciano de Salud, CSM Cartagena, Murcia, Spain
3
Servicio Murciano de Salud, Hospital Reina Sofia, Murcia, Spain
4
Servicio Murciano de Salud, CSM Lorca, Murcia, Spain
∗
Corresponding author.
The aim of this study is the approach to mental illness and specifi-
cally in seriousmood disorders, long-term treatments that improve
adhesion as continuous treatments ensure compliance are needed,
they minimize the risk of relapse and readmission and therefore
increase the chances to have a good fit and social, relational and
even occupational functioning. We analyzed a sample of 42 male
diagnosed with schizophrenia, schizoaffective disorder, chronic
delusional disorder that starts treatment with paliperidone palmi-
tate in outpatients. It is analyzed the dose of paliperidone palmitate
employed for stabilization and family satisfaction at the time of
stabilization is analyzed in the study. Our results are that the mean
dose of paliperidone palmitate is 138mg. The patient diagnosed
with schizophrenia are 47.6% and the average dose is 132.5mg.
Chronic delusional disorder is 2.3% and the mean dose 50mg. Other
comorbiditymood disorders are 21.4% and themean dose is183mg.
Other disorders (F70, F72
. . .
) are 28.5% and mean dose 133mg. The
average family satisfaction (minimum 1 up to 5) is 4, with the high-